Abstract
Intracavernosal injection therapy is now extensively used in the treatment of erectile disorder. It is effective in promoting erectile function in at least 80% of unselected patients. Overall, there is an extensive literature on this approach to treatment but the majority of papers relate to pharmacological, urologic or mechanistic issues. Reported studies that include psychological and behavioural aspects are scattered thinly throughout the literature. This paper attempts to review these aspects of intracavernosal injection therapy and emphasizes the desirability of the combined sex therapy-intracavernosal injection approach to the management of erectile disorder.